Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
QBIOTICS WELCOMES STEPHEN DOYLE AS CHIEF EXECUTIVE OFFICER 2024-08-05 19:00
So-Young to Report Second Quarter 2024 Financial Results on August 23, 2024 2024-08-05 17:00
Formosa Pharmaceuticals Announces Licensing Agreement with Apotex Inc., for Commercialization of Clobetasol Propionate Ophthalmic Suspension for Ocular Surgery Relief and Recovery 2024-08-05 16:30
INAUGURAL NUHS SCIENTIFIC & INNOVATION SUMMIT CHAMPIONS PREDICTIVE, PRECISE AND PERSONALISED CARE 2024-08-03 14:02
Latest Updates on the 7th China International Import Expo Unveiled 2024-08-02 12:26
Novel Non-Covalent Hits Against GPX4 Identified Using the RiDYMO® Reinforced Dynamics Platform of DP Technology 2024-08-01 17:00
MGI Tech Partners with UNALM and Inca Tops to Enhance Alpaca Fiber and Strengthen Peru's Textile Industry 2024-08-01 15:47
WuXi Biologics' Four Manufacturing Facilities and Biosafety Testing Center Certified Again by European Medicines Agency for Ten Biologics 2024-08-01 15:00
Medicilon and Hengrui Pharma Deepen Strategic Collaboration to Support Innovation in ADCs, Small Nucleic Acids, and CGT Drugs 2024-07-31 22:39
SURGLASSES Announces Successful First Clinical Implementation of Caduceus S AR Surgical Navigation System in Thailand 2024-07-31 21:00
JelloX Biotech collaborates with Mayo Clinic to develop AI enhanced 3D pathology imaging technology 2024-07-31 17:00
Fapon Delivers Customized IVD Solutions for the US Market at ADLM 2024 2024-07-31 14:42
FDA Grants Orphan Drug Designation (ODD) Status to Zymedi's ZMA001 for Pulmonary Arterial Hypertension 2024-07-31 08:00
Porton Advanced and Geneseed Biotech Enter into Strategic Collaboration to Focus on Advancing circRNA Innovative Therapeutics 2024-07-30 22:00
Baird Medical Announces Engagement and Education Program for the Development of Thyroid Microwave Ablation Technology 2024-07-30 17:00
Synthetica Pioneering Closes a Series A Funding Round to Support Development of Oncolytic Bacterial Therapy for Solid Tumors 2024-07-30 14:00
Bridge Biotherapeutics Announces Completion of Enrollment in the Phase 2a Clinical Study of BBT-877 for the Treatment of Idiopathic Pulmonary Fibrosis 2024-07-30 06:00
Daewoong Pharmaceutical Receives Positive Recommendation from IDMC to Continue Developing its First-in-Class PRS Inhibitor, Bersiporocin 2024-07-29 20:00
Despite External Challenges, WuXi AppTec Maintained Stable Operations in First Half of 2024; Revenue and Profit of the Second Quarter Both Steadily Improved QoQ as Expected, with Revenue Up 16.0% QoQ and Adjusted Non-IFRS Net Profit Up 28.5% QoQ 2024-07-29 19:05
Akeso's sBLA for Ivonescimab in 1L Treatment of PD-L1 Positive NSCLC Accepted by NMPA 2024-07-29 17:26
1 29 30 31 32 33 809